From professional translators, enterprises, web pages and freely available translation repositories.
pergolide
pergolidi
Last Update: 2014-12-09
Usage Frequency: 23
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
pergolide (product)
pergolidi
Last Update: 2014-12-09
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
pergolide [chemical/ingredient]
pergolidi
Last Update: 2014-12-09
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
cabergoline, lisuride and pergolide (for parkinson’ s disease).
parkinsonin taudin hoitoon), kabergoliinia, lisuridia tai pergolidia (käytetään parkinsonin taudin hoitoon).
Last Update: 2011-10-23
Usage Frequency: 2
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
lisuride, pergolide: risk of vasoconstriction and increase in blood pressure.
lisuridi, pergolidi: verisuonten supistumisen ja verenpaineen kohoamisen vaara.
Last Update: 2012-04-10
Usage Frequency: 2
Quality:
drugs shown in animal studies not to interfere with datscan imaging include pergolide.
eläinkokeissa on havaittu, että pergolidi ei häiritse datscan- kuvantamista.
Last Update: 2012-04-10
Usage Frequency: 3
Quality:
medicinal products shown in animal studies not to interfere with datscan imaging include pergolide.
eläinkokeissa on havaittu, että esim. pergolidi ei häiritse datscan-kuvantamista.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
bromocriptine, cabergoline, lisuride, pergolide: risk of vasoconstriction and increase in blood pressure.
bromokriptiini, kabergoliini, lisuridi, pergolidi: vasokonstriktion ja kohonneen verenpaineen vaara.
Last Update: 2012-04-10
Usage Frequency: 3
Quality:
the following combinations are not recommended: • bromocriptine • cabergoline • lisuride, pergolide: risk of vasoconstriction and increase in blood pressure.
valmisteen yhdistäminen seuraaviin aineisiin ei ole suositeltavaa: • bromokriptiini • kabergoliini • lisuridi, pergolidi: verisuonten supistumisen ja verenpaineen kohoamisen vaara.
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
haemorhagic stroke, due to the alpha-mimetic activity of the vasoconstrictor, in combination with vasoconstrictors such as bromocriptine, pergolide, lisuride, cabergoline, ergotamine, dihydroergotamine or any other decongestant drug used as nasal decongestant, either by oral route or by nasal route (phenylpropanolamine, phenylephrine, ephedrine...) .
vasokonstriktorin alfa-mimeettisestä aktiivisuudesta johtuen, kun se yhdistetään verisuonia supistavaan aineeseen kuten bromokriptiiniin, pergolidiin, lisuridiin, kabergoliiniin, ergotamiiniin, dihydroergotamiiniin tai muuhun dekongestanttiin, jota käytetään nenää avaavana, joko suun tai nenän kautta annosteltuna (fenyylipropanoliamiini, fenyyliefedriini, efedriini...) .
Last Update: 2008-03-04
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.